Literature DB >> 19496179

Alpha-fetoprotein and serum golgi phosphoprotein 2 are equally discriminative in detecting early hepatocellular carcinomas.

Marc-Oliver Riener, Frank Stenner, Heike Liewen, Claus Hellerbrand, Marcus Bahra, Glen Kristiansen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19496179     DOI： 10.1002/hep.23053

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  5 in total

Review 1.  An update of biochemical markers of hepatocellular carcinoma.

Authors:  Abdulaziz Ajlan M AlSalloom
Journal:  Int J Health Sci (Qassim)       Date:  2016-01

Review 2.  Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta-analysis.

Authors:  Ying Zhou; Xin Yin; Jun Ying; Boheng Zhang
Journal:  BMC Cancer       Date:  2012-01-16       Impact factor: 4.430

3.  GP73 represses host innate immune response to promote virus replication by facilitating MAVS and TRAF6 degradation.

Authors:  Xuewu Zhang; Chengliang Zhu; Tianci Wang; Hui Jiang; Yahui Ren; Qi Zhang; Kailang Wu; Fang Liu; Yingle Liu; Jianguo Wu
Journal:  PLoS Pathog       Date:  2017-04-10       Impact factor: 6.823

4.  GOLPH2, a gene downstream of ras signaling, promotes the progression of pancreatic ductal adenocarcinoma.

Authors:  Juan Duan; Xiaoguang Li; Shan Huang; Yanhua Zeng; Yan He; Hekun Liu; Dexin Lin; Dongdong Lu; Min Zheng
Journal:  Mol Med Rep       Date:  2018-01-15       Impact factor: 2.952

Review 5.  Golgi Phosphoprotein 73: The Driver of Epithelial-Mesenchymal Transition in Cancer.

Authors:  Yiming Liu; Xinyang Hu; Shiyao Liu; Sining Zhou; Zhi Chen; Hongchuan Jin
Journal:  Front Oncol       Date:  2021-12-07       Impact factor: 6.244
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.